ACTOS otherwise known as pioglitazone is a medication to be use by diabetics to help control blood sugar levels. While ACTOS does indeed lower blood sugar levels it however, does have a potentially very unfortunate side effect of bladder cancer. While the drug its self has been pulled by a few countries it remains in circulation within the United States. As such there has been a number of Wrongful Death Lawsuit brought against the company in regards to the use of ACTOS.
ACTOS and its ties to Bladder Cancer
Several recent studies have shown an increased risk of bladder cancer from the use of ACTOS in type 2 diabetes patients. The Food and Drug Administration (FDA) has found that there is a 40% increased risk of bladder cancer based on standard dosage and duration of use. Additionally the British Medical Journal found that as of 2012 there is as much as an 83% increased risk of bladder cancer from prolonged use of ACTOS.
What is Bladder Cancer
Bladder cancer is one of the most prevalent cancers in the world as of 2012. This affects nearly 74,000 people a year and kills roughly 16,000 people. Bladder cancer like other cancers results in an abnormal growth developing on or inside the bladder resulting in more frequent urination, blood in the urine, back pain and eventually death if untreated.
Class action lawsuit
There is estimated to be over 10,000 ACTOS Bladder Cancer Lawsuits currently with an expected increase into 2015 and beyond. With the FDA’s recent requirement of a warning label being placed on the prescription bottle and included in the medical insert adds extra legitimacy to current and future lawsuits filed against Tekeda, the manufacturers of ACTOS. As of 2015 Tekeda has yet to make any statement regarding the risk of Bladder Cancer from ACTOS, the requirement to list the risk of Bladder Cancer on the bottle and in the medical insert or regarding any of the class action suits filed against them.
Nothing officially has resulted from the various medical studies or class action suits connected to ACTOS other than the addition of a warning on the bottle and included in the medical insert accompanying it. However, several countries suspended the use of ACTOS in 2011 resulting in Takeda pulling ACTOS from these markets. In the end ACTOS continues to be sold and distributed within the United States and other countries despite the severe and life threatening side effects of bladder cancer.